Search Results for "Alterna Cigs Free Trial"

21:52 EDT 30th June 2015 | BioPortfolio

Matching Channels

Free perforation

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the ...

Xofigo (radium-223 dichloride)

New treatment for castration-resistant prostate cancer (CRPC) patients with bone metastases. Xofigo shown in a pivotal phase III trial to significantly improve overall survival. Xofigo® with...

Vitamin E Toxicity

Research has not found any adverse effects from consuming vitamin E in food. However, high doses of alpha-tocopherol supplements can cause hemorrhage and interrupt blood coagulation in animals, and ...

Contract Research Organization news

A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form o...

Matching News

E-cigarette vapor, even when nicotine-free, found to damage lung cells

With the use of e-cigarettes on the rise, especially among young people, research to uncover the health effects of e-cigs is becoming increasingly important. In a new study, researchers find that e-ci...

Schools Start Treating E-Cigs as Drug Paraphernalia

Read more about Schools Start Treating E-Cigs as Drug Paraphernalia

Novel Polymer and Carrier-Free Drug-Coated Stent Trial Completes Enrollment

Biosensors International has announced completion of patient enrollment in LEADERS Free Japan, a ground-breaking trial involving BioFreedom, the company’s novel polymer and carrier-free drug-coated ...

Are E-Cigs a Gateway to Smoking?

(MedPage Today) -- Most young people who use them also use other forms of tobacco.

E-Cigs Little Help in Kicking Real Cig Habit

(MedPage Today) -- Benefits seen at 1 month evaporate at 3 to 6 months

Teens Take Up E-Cigs Instead of Smoking

(MedPage Today) -- Overall tobacco use among adolescents rose in 2014 over the previous year.

Ascletis Files Clinical Trial Applications for Hepatitis C Drugs in China, Taiwan

Ascletis today announced that clinical trial applications for its interferon (IFN)-free regimen to treat chronic hepatitis C (CHC) have been filed and accepted by both China Food and Drug Administrati...

ATS 2015: Discoveries, CF Advances, E-Cigs

(MedPage Today) -- American Thoracic Society celebrates its 110th anniversary at annual meeting.

Matching PubMed Articles

Effectiveness of the Electronic Cigarette: An Eight-Week Flemish Study with Six-Month Follow-up on Smoking Reduction, Craving and Experienced Benefits and Complaints.

Smoking reduction remains a pivotal issue in public health policy, but quit rates obtained with traditional quit-smoking therapies remain disappointingly low. Tobacco Harm Reduction (THR), aiming at l...

Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit.

Electronic cigarettes (e-Cigs) are an attractive long-term alternative nicotine source to conventional cigarettes. Although they may assist smokers to remain abstinent during their quit attempt, studi...

Large-Scale Micro- and Nano-Patterns of Cu(In, Ga)Se2 Thin Film Solar Cells by Mold-Assisted Chemical Etching Process.

A reactive mold-assisted chemical etching (MACE) process through an easy-to-make agarose stamp soaked in bromine methanol etchant to rapidly imprint larger area micro- and nano- arrays on CIGS substra...

Exposure to Electronic Cigarettes Impairs Pulmonary Anti-Bacterial and Anti-Viral Defenses in a Mouse Model.

Electronic cigarettes (E-cigs) have experienced sharp increases in popularity over the past five years due to many factors, including aggressive marketing, increased restrictions on conventional cigar...

Outcomes and endpoints in trials of cancer treatment: the past, present, and future.

Cancer treatment should allow patients to live better or longer lives, and ideally, both. Trial endpoints should show clinically meaningful improvements in patient survival or quality of life. Alterna...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement